“Company” or “we” or “our” or “us”) would like to inform management discussion and analysis for its results of operations from the consolidated financial statements for the three months period ended March 31

DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 No. DOD128/2563

“Company” or “we” or “our” or “us”) would like to inform management discussion and analysis for its results of operations from the consolidated financial statements for the Nine months ended September 30

Summary of operations and the factors that make a significant change Summary of Operations for the Year 2023 Operation Overview Annual Balance Change 2023 2022 2023 VS 2022 Million baht (MB) (MB) % Total

financial investors in SSG III who have no involvement with the operations of SSG III and do not have any relationship with the Company which would led to them being considered as connected persons of the

Convening the Extraordinary General Meeting of Shareholders No. 1/2020 To: The President The Stock Exchange of Thailand Enclosure: 1. Debt to Equity Conversion Scheme of Jutha Maritime Public Company Limited

Management Discussion & Analysis of Business Operation Bangchak Corporation Public Company Limited For the 3rd quarter ended September 30th, 2018 Management Discussion and Analysis of Business

for operations. - Trade and other payables increased by Baht 94.18 million, because the Company order packages and raw materials for manufacturing to customer. - Liabilities under financial lease

HOLDINGS PUBLIC COMPANY LIMITED FOR THE SECOND QUARTER 2019 THREE MONTHES AND SIX MONTHS 1. STATEMENTS OF COMPREHENSIVE INCOME 1.1 Revenues from sales and services (Unit: Million Baht) For the second quarter

institutions for operations. - Trade and other payables decreased by Baht 3.03 million, because the Company paid packages and raw materials. - Liabilities under financial lease agreements increased by Baht 70.71